L-Lysine News
L-Lysine currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for L-Lysine with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: See EMA product information
- Evidence level: L5
- Predicted indications (20):
- gastroparesis (disease) (99.8%)
- congenital prothrombin deficiency (99.1%)
- obsolete vitamin D deficiency (99.0%)
- dyspepsia (98.7%)
- familial visceral myopathy (98.4%)
- vitamin deficiency disorder (98.2%)
- hypophosphatemic rickets (98.0%)
- renal tubular acidosis (97.8%)
- biotin metabolic disease (97.8%)
- postgastrectomy syndrome (97.3%)
- albinism-deafness syndrome (97.2%)
- postmenopausal osteoporosis (97.0%)
- intestinal obstruction (97.0%)
- myopathic intestinal pseudoobstruction (96.7%)
- unclassified intestinal pseudoobstruction (96.7%)
- stomach disease (96.7%)
- neuronal intestinal dysplasia, type B (96.5%)
- acne (disease) (96.5%)
- familial isolated hypoparathyroidism due to impaired PTH secretion (96.2%)
- hereditary hypophosphatemic rickets (95.9%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.